We are live on !
Find out more
Emerald Advisers Portfolio holdings
AUM
$4.25B
Turnover
24.28%
1-Year Est. Return
141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
(+34%)
Cap. Flow
-$109M
Cap. Flow % of AUM
Cap. Flow %
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39
Avg Time Held
2.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Legence Corp
LGN
|
+$53.3M |
| 2 |
Sensient Technologies
SXT
|
+$43.9M |
| 3 |
InterDigital
IDCC
|
+$35.5M |
| 4 |
Axcelis
ACLS
|
+$34.7M |
| 5 |
Terex
TEX
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$137M |
| 2 |
Credo Technology Group
CRDO
|
+$94.7M |
| 3 |
TTM Technologies
TTMI
|
+$85.3M |
| 4 |
Fabrinet
FN
|
+$68.7M |
| 5 |
Sterling Infrastructure
STRL
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Industrials | 23.28% |
| 3 | Healthcare | 21.93% |
| 4 | Financials | 9.1% |
| 5 | Consumer Discretionary | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
nLIGHT
LASR
$2.14B
| $51.3M | 1.21% |
736,848
-9,826
| -1% | -$686K |
2025 Q2
4 quarters
|
|
27
Spyre Therapeutics
SYRE
$8.69B
| $50.4M | 1.19% |
567,430
-45,935
| -7% | -$3.35M |
2024 Q3
7 quarters
|
|
28
UMB Financial
UMBF
$10.1B
| $49.4M | 1.16% |
345,687
+78,249
| +29% | +$10.1M |
2024 Q3
7 quarters
|
|
29
Boot Barn
BOOT
$3.52B
| $49.3M | 1.16% |
300,226
+91,801
| +44% | +$14.9M |
2024 Q4
6 quarters
|
|
30
Rush Street Interactive
RSI
$1.95B
| $48.8M | 1.15% |
1,639,592
+66,092
| +4% | +$1.74M |
2024 Q4
6 quarters
|
|
|
31
Sensient Technologies
SXT
$5.63B
| $48.7M | 1.15% |
+394,927
| New | +$43.9M |
2026 Q2
0 quarters
|
|
32
BillionToOne Inc
BLLN
$4.94B
| $45.1M | 1.06% |
375,858
+136,296
| +57% | +$12.4M |
2025 Q4
2 quarters
|
|
33
Agilysys
AGYS
$3.27B
| $44.7M | 1.05% |
427,845
+104,334
| +32% | +$8.08M |
2023 Q2
12 quarters
|
|
34
Astronics
ATRO
$2.66B
| $41.8M | 0.98% |
513,984
-24,967
| -5% | -$1.7M |
2025 Q4
2 quarters
|
|
|
35
TTM Technologies
TTMI
$10.8B
| $41.4M | 0.98% |
221,627
-528,790
| -70% | -$85.3M |
2024 Q3
7 quarters
|
|
36
Compass
COMP
$7.46B
| $40.6M | 0.96% |
3,296,616
+638,150
| +24% | +$5.32M |
2025 Q3
3 quarters
|
|
37
Freshpet
FRPT
$3.01B
| $39.8M | 0.94% |
673,730
+193,027
| +40% | +$11M |
2015 Q3
43 quarters
|
|
38
Life Time Group Holdings
LTH
$9.11B
| $39.7M | 0.93% |
971,490
+314,982
| +48% | +$10M |
2025 Q1
5 quarters
|
|
39
First Advantage
FA
$3.38B
| $39.5M | 0.93% |
2,188,875
+1,041,010
| +91% | +$15.1M |
2021 Q2
20 quarters
|
|
|
40
Terex
TEX
$6.07B
| $39.5M | 0.93% |
+545,046
| New | +$34.1M |
2026 Q2
0 quarters
|
|
41
Cytokinetics
CYTK
$8.74B
| $39M | 0.92% |
457,956
+259,145
| +130% | +$18.6M |
2026 Q1
1 quarter
|
|
42
IPG Photonics
IPGP
$3.15B
| $38.3M | 0.9% |
326,701
+21,785
| +7% | +$2.5M |
2025 Q3
3 quarters
|
|
43
National Vision
EYE
$1.4B
| $38.1M | 0.9% |
2,006,691
+504,047
| +34% | +$10.3M |
2020 Q1
25 quarters
|
|
44
Diodes
DIOD
$4.09B
| $37.8M | 0.89% |
345,473
+164,420
| +91% | +$16.7M |
2026 Q1
1 quarter
|
|
45
Herc Holdings
HRI
$4.4B
| $37.4M | 0.88% |
+261,155
| New | +$33.7M |
2026 Q2
0 quarters
|
|
46
Synaptics
SYNA
$4.66B
| $37.1M | 0.87% |
298,552
-31,364
| -10% | -$3.54M |
2025 Q4
2 quarters
|
|
47
MaxLinear
MXL
$6.87B
| $35.9M | 0.84% |
+280,350
| New | +$19.8M |
2026 Q2
0 quarters
|
|
48
Veradermics Inc
MANE
$5.71B
| $35.5M | 0.83% |
288,370
+155,834
| +118% | +$14.6M |
2026 Q1
1 quarter
|
|
49
Varonis Systems
VRNS
$5.59B
| $35.3M | 0.83% |
841,193
-27,828
| -3% | -$816K |
2016 Q3
39 quarters
|
|
50
Palvella Therapeutics
PVLA
$1.82B
| $35.1M | 0.83% |
229,486
+67,986
| +42% | +$8.25M |
2026 Q1
1 quarter
|
|
Similar funds
CAM
Emerald Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.
- Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
- Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
- Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
- Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
- Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
- Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
- Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.
Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.